EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in db/db Diabetic Mice

Anton I Korbut iD, Elizaveta A Ananishnikova, Nikolai B Orlov, Nataliya P Bgatova iD, Natalia A Muraleva iD, Evgenii L Zavyalov, Vladimir I Konenkov, Vadim V Klimontov

International Journal of Molecular Sciences · 21.07.2026 · 27 (14) · 6483

DOI: 10.3390/ijms27146483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.07.2026. Verfasst von Anton I Korbut und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sc…. Hauptthemen laut MEDLINE: Linagliptin, Metformin, Benzhydryl Compounds, Glucosides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Research Institute of Clinical and Experimental Lymphology—Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating data indicate a role for the dysregulation of the cell cycle, autophagy and apoptosis in diabetic kidney disease. We aimed to evaluate the mediators of the PI3K/Akt and MAPK/ERK signaling pathways in the kidney of db/db mice, a model of type 2 diabetes, treated by the SGLT2 inhibitor empagliflozin, the DPP4 inhibitor linagliptin, and metformin. Eight-week-old male db/db mice were randomly assigned to treatment by these agents or vehicle for 8 weeks. Age-matched db/+ mice acted as controls. AMPKα1 and PI3Kp110β were evaluated in the renal cortex and medulla by Western Blot. Phosphorylated forms of principal molecules involved in the PI3K/Akt and MAPK/ERK pathways were assessed by multiplex analysis. Db/db mice had decreased PI3Kp110β, increased phospho-PTEN, HSP27 and MEK1 in the renal cortex and medulla, BAD in the renal cortex and decreased phospho-rpS6 in the renal medulla. Empagliflozin prevented the changes in the levels of cortical PI3Kp110β, phospho-MEK1, and medullar phospho-PTEN. Linagliptin restored PI3Kp110β levels. Both agents further decreased medullar phospho-rpS6. Metformin upregulated cortical AMPKα1, medullar PI3Kp110β, phospho-GSK-3α/β and MEK1, and increased phospho-HSP27 in the renal cortex and medulla. The data may provide further explanation of the mechanism underlying the development of diabetic kidney disease, as well as the renal protective effect of anti-diabetic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinagliptinMetforminBenzhydryl CompoundsGlucosidesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktKidneyDiabetes Mellitus, Type 2MAP Kinase Signaling SystemDiabetes Mellitus, ExperimentalAnimalsMiceMaleHypoglycemic AgentsSignal TransductionDiabetic Nephropathies

Stichwörter der Autor:innen

MAPK/ERK signalingPI3K/Akt signalingchronic kidney diseaseempagliflozinlinagliptinmetformintype 2 diabetes

Substanzen

LinagliptinMetforminBenzhydryl CompoundsempagliflozinGlucosidesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktHypoglycemic Agents

Autor:innen und Institutionen

  • Research Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL-Branch of IC&G SB RAS), Novosibirsk 630117, Russia.
  • Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (IC&G SB RAS); Novosibirsk 630090, Russia.

ORCID-Profile: Anton I Korbut, Nataliya P Bgatova, Natalia A Muraleva

Förderung

  • Research Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
  • Research Institute of Clinical and Experimental Lymphology—Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

Zitieren

APA

Korbut, A. I., Ananishnikova, E. A., Orlov, N. B., Bgatova, N. P., Muraleva, N. A., Zavyalov, E. L., Konenkov, V. I., & Klimontov, V. V. (2026). Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in db/db Diabetic Mice. International Journal of Molecular Sciences, 27(14), 6483. https://doi.org/10.3390/ijms27146483

Vancouver

Korbut AI, Ananishnikova EA, Orlov NB, Bgatova NP, Muraleva NA, Zavyalov EL, et al. Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in db/db Diabetic Mice. International Journal of Molecular Sciences. 2026;27(14):6483. doi:10.3390/ijms27146483

BibTeX
@article{Korbut2026,
  author = {Korbut, Anton I and Ananishnikova, Elizaveta A and Orlov, Nikolai B and Bgatova, Nataliya P and Muraleva, Natalia A and Zavyalov, Evgenii L and Konenkov, Vladimir I and Klimontov, Vadim V},
  title = {Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in db/db Diabetic Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6483},
  doi = {10.3390/ijms27146483}
}
Kostenlos starten →